Lack of an association of PD-1 and its ligand genes with Behcet's disease in a Chinese Han population

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Meng, Qianli ^a   Guo, Haike ^a   Hou, Shengping ^b   Jiang, Zhengxuan ^b   Kijlstra, Aize ^c   Yang, Peizeng ^b  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APHTHOUS ULCER; ARTHRITIS; ARTICLE; BEHCET DISEASE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENITAL ULCER; GENOTYPE; HUMAN; IMMUNE RESPONSE GENE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRICK TEST; PROGRAMMED CELL DEATH 1 GENE; PROGRAMMED CELL DEATH 1 LIGAND 1 GENE; PROGRAMMED CELL DEATH 1 LIGAND 2 GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; CHINA; ETHNIC GROUP; GENETIC PREDISPOSITION; GENETICS;

LIGAND; PDCD1 PROTEIN, HUMAN; PROGRAMMED DEATH 1 RECEPTOR;

ADULT; BEHCET SYNDROME; CASE-CONTROL STUDIES; CHINA; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIGANDS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGRAMMED CELL DEATH 1 RECEPTOR;

EID: 80054791943     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025345     Document Type: Article

References (40)

1. Sakane T, Takeno M, Suzuki N, Inaba G, (1999) Behçet's disease. N Engl J Med 341: 1284-1291.
2. Keino H, Okada AA, (2007) Behcet's disease: global epidemiology of an Old Silk Road disease. Br J Ophthalmol 91: 1573-1574.
3. Yang P, Fang W, Meng Q, Ren Y, Xing L, et al. (2008) Clinical features of Chinese patients with Behcet's disease. Ophthalmology 115: 312-318.
4. Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR, (1999) Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54: 213-220.
5. Mizuki N, Yabuki K, Ota M, Katsuyama Y, Ando H, et al. (2002) Analysis of microsatellite polymorphism around the HLA-B locus in Iranian patients with Behcet's disease. Tissue Antigens 60: 396-399.
6. Cohen R, Metzger S, Nahir M, Chajek-Shaul T, (2002) Association of the MIC-A gene and HLA-B51 with Behcet's disease in Arabs and non-Ashkenazi Jews in Israel. Ann Rheum Dis 61: 157-160.
7. Yabuki K, Mizuki N, Ota M, Katsuyama Y, Palimeris G, et al. (1999) Association of MICA gene and HLA-B*5101 with Behcet's disease in Greece. Invest Ophthalmol Vis Sci 40: 1921-1926.
8. Park K, Kim N, Nam J, Bang D, Lee ES, (2006) Association of TNFA promoter region haplotype in Behcet's Disease. J Korean Med Sci 21: 596-601.
9. Hou S, Yang P, Du L, Zhou H, Lin X, et al. (2008) SUMO4 gene polymorphisms in Chinese Han patients with Behcet's disease. Clin Immunol 129: 170-175.
10. Jiang Z, Yang P, Hou S, Du L, Xie L, et al. (2010) IL-23R gene confers susceptibility to Behcet's disease in a Chinese Han population. Ann Rheum Dis 69: 1325-1328.
11. Keir ME, Butte MJ, Freeman GJ, Sharpe AH, (2008) PD-1 and its ligands in tolerance and immunity. Ann Rev Immunol 26: 677-704.
12. Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T, (2001) PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci U S A 98: 13866-13871.
13. Nishimura H, Nose M, Hial H, Minato N, Honjo T, (1999) Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11: 141-151.
14. Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, et al. (2001) Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291: 319-322.
15. Meng Q, Yang P, Li B, Zhou H, Huang X, et al. (2006) CD4+PD-1+ T cells act as regulatory cells during the induction of anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci 47: 4444-4452.
16. Prokunina L, Castillejo-Lopez C, Oberg F, Gunnarsson I, Berg L, et al. (2002) A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 32: 666-669.
17. Ferreiros-Vidal I, Gomez-Reino JJ, Barros F, Carracedo A, Carreira P, et al. (2004) Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. Arthritis Rheum 50: 2590-2597.
18. Sanghera DK, Manzi S, Bontempo F, Nestlerode C, Kamboh MI, (2004) Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphospholipid antibodies. Hum Genet 115: 393-398.
19. Thorburn CM, Prokunina-Olsson L, Sterba KA, Lum RF, Seldin MF, et al. (2007) Association of PDCD1 genetic variation with risk and clinical manifestations of systemic lupus erythematosus in a multiethnic cohort. Genes Immun 8: 279-287.
20. Velazquez-Cruz R, Orozco L, Espinosa-Rosales F, Carreno-Manjarrez R, Solis-Vallejo E, et al. (2007) Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus. Eur J Hum Genet 15: 336-341.
21. Kong EK, Prokunina-Olsson L, Wong WH, Lau CS, Chan TM, et al. (2005) A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum 52: 1058-1062.
22. Nielsen C, Hansen D, Husby S, Jacobsen BB, Lillevang ST, (2003) Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens 62: 492-497.
23. Ni R, Ihara K, Miyako K, Kuromaru R, Inuo M, et al. (2007) PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children. Hum Genet 121: 223-232.
24. Kroner A, Mehling M, Hemmer B, Rieckmann P, Toyka KV, et al. (2005) A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 58: 50-57.
25. Lee SH, Lee YA, Woo DH, Song R, Park EK, et al. (2006) Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population. Arthritis Res Ther 8: R163.
26. Newby PR, Roberts-Davies EL, Brand OJ, Heward JM, Franklyn JA, et al. (2007) Tag SNP screening of the PDCD1 gene for association with Graves' disease. Clin Endocrinol (Oxf) 67: 125-128.
27. Lin SC, Yen JH, Tsai JJ, Tsai WC, Ou TT, et al. (2004) Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum 50: 770-775.
28. Abelson AK, Johansson CM, Kozyrev SV, Kristjansdottir H, Gunnarsson I, et al. (2007) No evidence of association between genetic variants of the PDCD1 ligands and SLE. Genes Immun 8: 69-74.
29. Fawwaz S, Nikamo P, Torn C, Landin-Olsson M, Lernmark A, et al. (2007) No evidence of association of the PDCD1 gene with Type 1 diabetes. Diabet Med 24: 1473-1477.
30. Ferreiros-Vidal I, D'Alfonso S, Papasteriades C, Skopouli FN, Marchini M, et al. (2007) Bias in association studies of systemic lupus erythematosus susceptibility due to geographical variation in the frequency of a programmed cell death 1 polymorphism across Europe. Genes Immun 8: 138-146.
31. Iwamoto T, Ikari K, Inoue E, Toyama Y, Hara M, et al. (2007) Failure to confirm association between PDCD1 polymorphisms and rheumatoid arthritis in a Japanese population. J Hum Genet 52: 557-560.
32. Meng Q, Liu X, Yang P, Hou S, Du L, et al. (2009) PD-1 genes may protect against extra-ocular manifestations in Chinese Han patients with Vogt-Koyanagi-Harada syndrome. Mol Vis 15: 386-392.
33. Wang SC, Lin CH, Ou TT, Wu CC, Tsai WC, et al. (2007) Ligands for programmed cell death 1 gene in patients with systemic lupus erythematosus. J Rheumatol 34: 721-725.
34. Hayashi M, Kouki T, Takasu N, Sunagawa S, Komiya I, (2008) Association of an A/C single nucleotide polymorphism in programmed cell death-ligand 1 gene with Graves' disease in Japanese patients. Eur J Endocrinol 158: 817-822.
35. Chou WC, Liao KW, Lo YC, Jiang SY, Yeh MY, et al. (1999) Expression of chimeric monomer and dimer proteins on the plasma membrane of mammalian cells. Biotechnol Bioeng 65: 160-169.
36. Choi S, Lee E, Kwon S, Park H, Yi JY, et al. (2005) Transmembrane domain-induced oligomerization is crucial for the functions of syndecan-2 and syndecan-4. J Biol Chem 280: 42573-42579.
37. Gül A, (2005) Behcet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4: 81-83.
38. Direskeneli H, (2006) Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? Rheumatology (Oxford) 45: 1461-465.
39. Wang SC, Chen YJ, Ou TT, Wu CC, Tsai WC, et al. (2006) Programmed death-1 gene polymorphisms in patients with systemic lupus erythematosus in Taiwan. J Clin Immunol 26: 506-511.
40. International Study Group for Behcet's Disease (1990) Criteria for diagnosis of Behcet's disease. Lancet 335: 1078-1080.